What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Endocrinology
- Gene
His main research concerns Internal medicine, Endocrinology, Leptin, Adiponectin and Insulin resistance.
Christos S. Mantzoros usually deals with Internal medicine and limits it to topics linked to Diabetes mellitus and Cohort.
His study in Endocrinology focuses on Adipose tissue, Adipokine, Hormone, Insulin and Resistin.
The study incorporates disciplines such as Metreleptin and Energy homeostasis in addition to Leptin.
His Adiponectin research is multidisciplinary, incorporating perspectives in Cancer and Blood plasma.
His research in Insulin resistance focuses on subjects like Myokine, which are connected to Adipocyte.
His most cited work include:
- Role of leptin in the neuroendocrine response to fasting (2641 citations)
- Adverse metabolic and cardiovascular consequences of circadian misalignment (1380 citations)
- Recombinant human leptin in women with hypothalamic amenorrhea. (662 citations)
What are the main themes of his work throughout his whole career to date?
Christos S. Mantzoros mostly deals with Internal medicine, Endocrinology, Leptin, Adiponectin and Insulin resistance.
Christos S. Mantzoros regularly links together related areas like Diabetes mellitus in his Internal medicine studies.
Borrowing concepts from Context, Christos S. Mantzoros weaves in ideas under Endocrinology.
Christos S. Mantzoros has included themes like Metreleptin and Weight loss in his Leptin study.
His research integrates issues of Cancer, Case-control study and Risk factor in his study of Adiponectin.
The concepts of his Body mass index study are interwoven with issues in Odds ratio and Prospective cohort study.
He most often published in these fields:
- Internal medicine (112.96%)
- Endocrinology (98.10%)
- Leptin (40.43%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (112.96%)
- Endocrinology (98.10%)
- Obesity (23.66%)
In recent papers he was focusing on the following fields of study:
Christos S. Mantzoros mainly investigates Internal medicine, Endocrinology, Obesity, Diabetes mellitus and Insulin resistance.
Internal medicine is a component of his Fatty liver, Nonalcoholic fatty liver disease, Leptin, Disease and Adiponectin studies.
His study on Leptin Deficiency is often connected to Lipodystrophy as part of broader study in Leptin.
His Obesity study incorporates themes from Intensive care medicine, Weight gain, Placebo, Type 2 diabetes and Risk factor.
His work investigates the relationship between Diabetes mellitus and topics such as Incidence that intersect with problems in Hazard ratio.
The various areas that Christos S. Mantzoros examines in his Insulin resistance study include Steatosis and Metabolic syndrome.
Between 2017 and 2021, his most popular works were:
- Severe obesity, increasing age and male sex are independently associated with worse in-hospital outcomes, and higher in-hospital mortality, in a cohort of patients with COVID-19 in the Bronx, New York. (279 citations)
- Obesity and cancer risk: Emerging biological mechanisms and perspectives. (153 citations)
- Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics. (143 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Cancer
His scientific interests lie mostly in Internal medicine, Endocrinology, Obesity, Type 2 diabetes and Insulin resistance.
His Internal medicine study integrates concerns from other disciplines, such as Diabetes mellitus, Gastroenterology and Bioinformatics.
His research in Leptin, Glucose homeostasis, Adipose tissue, Follistatin and Hormone are components of Endocrinology.
He has researched Leptin in several fields, including Glucose tolerance test, Familial partial lipodystrophy, Case-control study and Impaired fasting glucose.
His biological study spans a wide range of topics, including Placebo, Pharmacotherapy, Intensive care medicine and Risk factor.
His Type 2 diabetes study combines topics from a wide range of disciplines, such as Metformin, Randomized controlled trial and Appetite.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
